- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cerus Corporation (CERS)
Cerus Corporation stock price live, this page displays NASDAQ CERS stock exchange data. View the CERS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cerus Corporation real time stock price chart below.
What Is the Cerus Corporation Stock Price Today?
The Cerus Corporation stock price today is 1.430.
What Is the Stock Symbol for Cerus Corporation?
The stock symbol for Cerus Corporation is ""CERS.""
What Stock Exchange Does Cerus Corporation Trade On?
Cerus Corporation is listed and trades on the NASDAQ stock exchange.
Is Cerus Corporation a Good Stock to Buy?
Determining whether Cerus Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CERS quote. (ISIN: US1570851014)
What Is the Cerus Corporation Stock Price Today?
The Cerus Corporation stock price today is 1.430.
What Is the Stock Symbol for Cerus Corporation?
The stock symbol for Cerus Corporation is ""CERS.""
What Stock Exchange Does Cerus Corporation Trade On?
Cerus Corporation is listed and trades on the NASDAQ stock exchange.
Is Cerus Corporation a Good Stock to Buy?
Determining whether Cerus Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CERS quote. (ISIN: US1570851014)
NASDAQ
Currency in USD
1.430
+0.050(+3.62%)
Closed·
After Hours
1.450+0.020(+1.40%)
·
Fair Value
An estimate of a Cerus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.400
1.450
52 wk Range
1.120
2.540
CERS Scorecard
Full Analysis
Stock price movements are quite volatile
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Cerus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.4001.450
52 wk Range
1.1202.540
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CERS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cerus's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
4.667
Upside
+226.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Cerus Corporation Company Profile
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Cerus Corporation Earnings Call Summary for Q1/2025
- Cerus reported Q1 2025 net loss of $7.7M ($0.04/share), meeting EPS forecasts; revenue of $48.9M missed expectations, causing 1.52% stock dip
- Product revenue up 13% YoY, with North American sales surging 22%; EMEA saw slight decline. Product gross margins improved to 58.8% from 55.4% in Q1 2024
- Full-year 2025 product revenue guidance set at $194-$200M; company aims for positive adjusted EBITDA and annual positive operating cash flow
- CEO emphasized mission to enhance blood component safety; COO highlighted ongoing confidence in INTERCEPT product offerings
- Analysts maintain strong buy consensus with $4/share median price target; InvestingPro data shows CERS has 1.7 beta, indicating high price volatility
Last Updated: 01/05/2025, 22:22
Read Full TranscriptCompare CERS to Peers and Sector
Metrics to compare | CERS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCERSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.0x | −4.3x | −0.5x | |
PEG Ratio | −0.34 | −0.12 | 0.00 | |
Price/Book | 4.8x | 3.0x | 2.6x | |
Price / LTM Sales | 1.4x | 3.4x | 3.2x | |
Upside (Analyst Target) | 262.3% | 42.5% | 44.1% | |
Fair Value Upside | Unlock | 1.0% | 6.2% | Unlock |
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.667
(+226.34% Upside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
-0.04 / -0.04
Revenue / Forecast
48.90M / 49.61M
People Also Watch
FAQ
What Stock Exchange Does Cerus Trade On?
Cerus is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Cerus?
The stock symbol for Cerus is "CERS."
What Is the Cerus Market Cap?
As of today, Cerus market cap is 274.32M.
What Is Cerus's Earnings Per Share (TTM)?
The Cerus EPS (TTM) is -0.10.
When Is the Next Cerus Earnings Date?
Cerus will release its next earnings report on 30 Jul 2025.
From a Technical Analysis Perspective, Is CERS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Cerus Stock Split?
Cerus has split 0 times.
How Many Employees Does Cerus Have?
Cerus has 622 employees.
What is the current trading status of Cerus (CERS)?
As of 22 Jul 2025, Cerus (CERS) is trading at a price of 1.43, with a previous close of 1.38. The stock has fluctuated within a day range of 1.40 to 1.45, while its 52-week range spans from 1.12 to 2.54.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.